FIA
ANVS icon

FNY Investment Advisers’s Annovis Bio ANVS Stock Holding History

FNY Investment Advisers’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,000
Closed -$2K – 856
2026
Q1 		$2K Sell
1,000
-1,000
-50% -$2.74K ﹤0.01% 655
2025
Q4 		$6K Hold
2,000
– – ﹤0.01% 706
2025
Q3 		$4K Buy
+2,000
New +$5K ﹤0.01% 941
2024
Q2 		– Sell
-400
Closed -$4 – 444
2024
Q1 		$4 Sell
400
-200
-33% -$2.18K ﹤0.01% 529
2023
Q4 		$11K Sell
600
-533
-47% -$4.73K 0.01% 301
2023
Q3 		$10K Buy
+1,133
New +$14K 0.01% 383
2022
Q3 		– Sell
-3,650
Closed -$41K – 640
2022
Q2 		$41K Buy
3,650
+3,050
+508% +$33.3K 0.03% 248
2022
Q1 		$8K Buy
+600
New +$8.67K 0.01% 481

Other funds holding ANVS

FNT
First National Trust Hermitage, Pennsylvania $2.95B AUM 27.19% 1-Year Est. Return
SG
Sherry Group Mountain Home, Arkansas $102M AUM
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
QWM
Quadcap Wealth Management Frisco, Texas $1.03B AUM 28.22% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

FNY Investment Advisers's ANVS Position: Q2 2026 in Review

FNY Investment Advisers sold out of Annovis Bio (ANVS) in Q2 2026, closing a stake of 1,000 shares — an estimated $2K sold.

FNY Investment Advisers first reported a position in ANVS in Q1 2022 and held it in 8 quarters. The position peaked at $41K in Q2 2022. 13 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • FNY Investment Advisers reported no remaining Annovis Bio position as of Q2 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 1,000 Annovis Bio shares in Q2 2026, an estimated $2K.
  • FNY Investment Advisers first reported a position in Annovis Bio in Q1 2022 and held it in 8 quarters.
  • FNY Investment Advisers's Annovis Bio position peaked at $41K in Q2 2022.
  • 13 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.